Lamdong Pharmaceutical JSC (HNX:LDP)

HNX:LDP Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019
Cash & Equivalents	11,451	16,205	16,619	65,159	28,257
Short-Term Investments	4,692	3,121	1,788	-	-
Cash & Short-Term Investments	16,144	19,326	18,407	65,159	28,257
Cash Growth	-16.47%	4.99%	-71.75%	130.59%	172.07%
Accounts Receivable	31,467	21,205	21,415	23,286	53,300
Other Receivables	10,808	11,216	10,819	432.72	1,143
Receivables	37,726	32,421	32,234	23,719	54,443
Inventory	48,962	37,751	55,919	54,575	94,621
Prepaid Expenses	2,076	442.65	957.04	284.73	599.99
Other Current Assets	51,716	50,273	51,458	545.85	958.51
Total Current Assets	156,624	140,214	158,976	144,283	178,879
Property, Plant & Equipment	42,555	46,329	55,742	60,718	87,627
Long-Term Investments	-	-	-	-	5
Other Intangible Assets	68.6	229.47	491.92	740.21	4,260
Other Long-Term Assets	7,800	8,000	13,164	10,180	10,933
Total Assets	207,048	194,773	228,374	215,921	281,704
Accounts Payable	31,545	23,549	31,801	13,964	59,830
Accrued Expenses	16,705	8,334	7,216	3,345	10,864
Short-Term Debt	55,026	65,960	70,298	29,960	90,679
Current Income Taxes Payable	-	562.22	1,063	7,209	5,959
Current Unearned Revenue	134.18	-	60	72	720
Other Current Liabilities	2,692	2,282	3,138	3,933	2,863
Total Current Liabilities	106,103	100,687	113,574	58,483	170,915
Long-Term Debt	-	-	591.64	2,339	9,980
Other Long-Term Liabilities	1,770	1,720	1,720	1,720	5,519
Total Liabilities	107,873	102,407	115,886	62,541	186,415
Common Stock	127,032	127,032	127,032	127,032	78,300
Retained Earnings	-27,856	-34,666	-14,543	26,348	16,086
Treasury Stock	-0.32	-0.32	-0.32	-0.32	-0.32
Comprehensive Income & Other	-	-	-	-	904.23
Shareholders' Equity	99,176	92,366	112,489	153,380	95,289
Total Liabilities & Equity	207,048	194,773	228,374	215,921	281,704
Total Debt	55,026	65,960	70,889	32,299	100,660
Net Cash (Debt)	-38,882	-46,634	-52,482	32,860	-72,402
Net Cash Per Share	-3060.24	-3671.83	-4132.07	2586.61	-9245.07
Filing Date Shares Outstanding	12.69	12.7	12.7	12.7	7.83
Total Common Shares Outstanding	12.69	12.7	12.7	12.7	7.83
Working Capital	50,521	39,527	45,402	85,800	7,964
Book Value Per Share	7814.39	7271.08	8855.18	12073.06	12167.08
Tangible Book Value	99,107	92,136	111,997	152,640	91,029
Tangible Book Value Per Share	7808.99	7253.02	8816.45	12014.79	11623.13
Construction In Progress	2,851	-	690.2	-	-3,102

Source: S&P Capital IQ. Standard template. Financial Sources.